feed,title,long_url,short_url
Benzinga,Huntington Bancshares Q2 Earnings Gets Mixed Analysts Reactions,https://benzinga.com/markets/equities/23/07/33350441/huntington-bancshares-q2-earnings-gets-mixed-analysts-reactions,https://da.gd/JLvDGZ
Benzinga,"Halozyme's Subcutaneous Drug Delivery: Analysts Initiate With 'Buy' Rating, Say Enhanze Tech Targets $41.7B Market",https://benzinga.com/general/biotech/23/07/33350464/halozymes-subcutaneous-drug-delivery-analysts-initiate-with-buy-rating-say-enhanze-tech-targets-4,https://da.gd/vHG9h
